Vice President, CMC Development & Drug Delivery Innovation Remote (anywhere in United States)

The Company is seeking a Vice President for CMC Development and Drug Delivery Innovation. The successful candidate will be responsible for owning and executing the Chemistry, Manufacturing, and Controls (CMC) strategy across a diverse portfolio of GLP-1-based therapies. This includes leading the development of drug substances, drug products, and device/combination products, with a focus on injectable and oral solid dose formulations. The role demands a highly cross-functional, leadership approach to advance the pipeline from late-stage clinical development to commercial launch readiness. The VP will also be tasked with ensuring compliance with global regulations, managing CMC and device risk, and leading a high-performing CMC and device engineering organization. Applicants must have a minimum of 15 years' progressive CMC leadership experience in the biotechnology or pharmaceutical industry, with a strong background in injectable combination products and oral solid dose formulation development. The role requires a proven track record in building and scaling technical teams, as well as experience in managing CDMO and device supplier relationships. The ideal candidate will be a hands-on operator, comfortable with both strategic planning and day-to-day execution, and possess excellent executive communication skills. A collaborative, cross-functional leadership style and the ability to operate with the ambiguity and resource constraints of a growth-stage biotech are essential. A talent for attracting, developing, and retaining strong technical leaders is also a key qualification.

Hiring Company

Kailera Therapeutics